Brentuximab Vedotin Consolidation Therapy after Autologous Stem-Cell Transplantation in Patients with High-Risk Hodgkin Lymphoma: Multi-Center Retrospective Study


Ozbalak M., Akay O. M. , PEHLİVAN M., Yildiz B., UZAY A., Yigenoglu T. N. , ...More

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, vol.21, 2021 (Journal Indexed in SCI) identifier

  • Publication Type: Article / Abstract
  • Volume: 21
  • Publication Date: 2021
  • Title of Journal : CLINICAL LYMPHOMA MYELOMA & LEUKEMIA
  • Keywords: relapsed and refractory, Hodgkin lymphoma, brentuximab vedotin, autologous stem cell transplantation, consolidation